Annual Shareholders Equity
$191.26 M
-$49.90 M-20.69%
December 31, 2024
Summary
- As of March 12, 2025, MLYS annual stockholders equity is $191.26 million, with the most recent change of -$49.90 million (-20.69%) on December 31, 2024.
- During the last 3 years, MLYS annual shareholders equity has risen by +$214.18 million (+934.27%).
- MLYS annual shareholders equity is now -20.69% below its all-time high of $241.15 million, reached on December 31, 2023.
Performance
MLYS Shareholders Equity Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Shareholders Equity
$191.26 M
-$45.67 M-19.28%
December 31, 2024
Summary
- As of March 12, 2025, MLYS quarterly stockholders equity is $191.26 million, with the most recent change of -$45.67 million (-19.28%) on December 31, 2024.
- Over the past year, MLYS quarterly shareholders equity has dropped by -$49.90 million (-20.69%).
- MLYS quarterly shareholders equity is now -41.70% below its all-time high of $328.05 million, reached on March 31, 2024.
Performance
MLYS Quarterly Shareholders Equity Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Shareholders Equity Formula
Shareholders Equity = Total Assets − Total Liabilities
MLYS Shareholders Equity Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -20.7% | -20.7% |
| 3 y3 years | +934.3% | -20.7% |
| 5 y5 years | +5417.1% | -20.7% |
MLYS Shareholders Equity Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -20.7% | +465.9% | -41.7% | +465.9% |
| 5 y | 5-year | -20.7% | +465.9% | -41.7% | +465.9% |
| alltime | all time | -20.7% | +465.9% | -41.7% | +465.9% |
Mineralys Therapeutics Shareholders Equity History
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2024 | $191.26 M(-20.7%) | $191.26 M(-19.3%) |
| Sep 2024 | - | $236.93 M(-18.3%) |
| Jun 2024 | - | $290.10 M(-11.6%) |
| Mar 2024 | - | $328.05 M(+36.0%) |
| Dec 2023 | $241.15 M | $241.15 M(-8.7%) |
| Sep 2023 | - | $264.01 M(-7.4%) |
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2023 | - | $285.01 M(-3.7%) |
| Mar 2023 | - | $295.88 M(-666.1%) |
| Dec 2022 | -$52.27 M(+128.0%) | -$52.27 M(+20.4%) |
| Sep 2022 | - | -$43.41 M(+89.4%) |
| Dec 2021 | -$22.93 M(+537.3%) | - |
| Dec 2021 | - | -$22.93 M |
| Dec 2020 | -$3.60 M | - |
FAQ
- What is Mineralys Therapeutics annual stockholders equity?
- What is the all time high annual shareholders equity for Mineralys Therapeutics?
- What is Mineralys Therapeutics annual shareholders equity year-on-year change?
- What is Mineralys Therapeutics quarterly stockholders equity?
- What is the all time high quarterly shareholders equity for Mineralys Therapeutics?
- What is Mineralys Therapeutics quarterly shareholders equity year-on-year change?
What is Mineralys Therapeutics annual stockholders equity?
The current annual shareholders equity of MLYS is $191.26 M
What is the all time high annual shareholders equity for Mineralys Therapeutics?
Mineralys Therapeutics all-time high annual stockholders equity is $241.15 M
What is Mineralys Therapeutics annual shareholders equity year-on-year change?
Over the past year, MLYS annual stockholders equity has changed by -$49.90 M (-20.69%)
What is Mineralys Therapeutics quarterly stockholders equity?
The current quarterly shareholders equity of MLYS is $191.26 M
What is the all time high quarterly shareholders equity for Mineralys Therapeutics?
Mineralys Therapeutics all-time high quarterly stockholders equity is $328.05 M
What is Mineralys Therapeutics quarterly shareholders equity year-on-year change?
Over the past year, MLYS quarterly stockholders equity has changed by -$49.90 M (-20.69%)